ATP13A2 and Parkinsonism: Recessive mutations in several genes, including the ATPase type 13A2 gene (ATP13A2/PARK9), can cause neurodegeneration with a very young (juvenile) onset, usually presenting with other clinical signs in addition to parkinsonism (such as dystonia, oculomotor disturbances, pyramidal signs, and dementia).